Gefitinib: An Updated Review of its Role in the Cancer Management, itsNanotechnological Interventions, Recent Patents and Clinical Trials

Gefitinib showed significant advantages in being more effective, safer and more stable, and the associated biopharmaceutical problems are addressed by the application of nanotechnology. The combination therapy using gefitinib and various anticancer molecules of natural and synthetic origin has shown an improved anticancer profile.